Verve Therapeutics gets grant for gene editing compositions to lower ldl cholesterol levels

Discover how Verve Therapeutics’ new patent for gene editing targeting the PCSK9 gene could revolutionize LDL cholesterol treatment and combat cardiovascular disease.

Lyell Immunopharma to acquire ImmPACT Bio, cut top programs

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 26, 2024

House panel passes bills to expand Medicare obesity drug coverage, cancer screening

WASHINGTON — A House committee overwhelmingly passed four bills on Thursday that would expand Medicare coverage of obesity drugs and cancer screening blood tests and

June 27, 2024

Atezolizumab by F. Hoffmann-La Roche for Ureter Cancer: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.